📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

First Africa-based clinical trial for novel type 2 oral poliovirus vaccine. (2024)

First Author: Cooper LV

Attributed to: MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(24)00053-9

PubMed Identifier: 38402883

Publication URI: http://europepmc.org/abstract/MED/38402883

Type: Journal Article/Review

Volume: 403

Parent Publication: Lancet (London, England)

Issue: 10432

ISSN: 0140-6736